G2GBIO
specializes in developing long acting microsphere products. We have been developing
unique InnoLAMP technology which can make monodisperse PLGA, PLA or PCL
microspheres for long acting drugs or dermal filler.
What Makes Us Different?
Precise Size & Release Control
Our
proprietary platform technology enables us to produce the microspheres with
exact sizes and finely controlled release profile.
Easy Scale-Up
InnoLAMP
technology differentiates in easy scale-up and simple aseptic process compared
to other conventional technologies.
Various Indications
Our technology can be
applied to various indications such as central nervous system diseases such as
dementia or schizophrenia, and chronic diseases such as cancer and diabetes. We
will gradually expand our target to various diseases with medical unmet need
for sustained release.
KR